Rise Advisors, LLC
- SEC CIK
- 0001831316
- Latest filing
- Jul 10, 2026
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by Rise Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −83−100.0% | Sold out | Holders |
| Q4 2024 | 83 | $2.10K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 83 | $2.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 83 | $3.07K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 83 | $3.48K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 83 | $3.29K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 83 | $2.28K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 83 | $2.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 83 | $2.99K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 83 | $3.70K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 83 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 83 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 83 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 83 | $3.21K | <0.1% | – | No prior filing | Holders |